Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 76, Issue 1, 1998, Pages 109-114

  Davidson, Ben ^a   Goldberg, Iris ^a   Gotlieb, Walter H ^a   Ben Baruch, Gilad ^a   Kopolovic, Juri ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cervical neoplasia; Collagen IV; Fibronectin; Laminin

Indexed keywords

MATRIX PROTEIN;

ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL; CANCER INVASION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEMBRANE DAMAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; UTERINE CERVIX CANCER;

EID: 0031962293     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(97)00161-9     Document Type: Article

References (21)

1. [1] Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68(1):4-17.
2. [2] Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988;57:375-413.
3. [3] Stenman S, Vaheri A. Fibronectin in human solid tumors. Int J Cancer 1981;27(4):427-35.
4. [4] Moro L, Colombi M, Molinari-Tosatti MP, Barlati S. Study of fibronectin mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis. Int J Cancer 1992;51:692-7.
5. [5] Auersperg N, Kruk PA, MacLaren IA, Watt FM, Myrdal SE. Heterogeneous expression of keratin, involucrin and extracellular matrix among subpopulations of a poorly differentiated human cervical carcinoma: possible relationships to patterns of invasion. Cancer Res 1989;49:3007-14.
6. [6] Tryggvason K. The laminin family. Curr Opin Cell Biol 1993;5:877-82.
7. [7] Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for Urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995;55:4132-9.
8. [8] Soini Y, Autio-Harmainen H. Synthesis and degradation of basement membranes in benign and malignant salivary glands tumor. A study by in situ hybridization. J Pathol 1993;170(3):291-6.
9. [9] Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A, Autio-Harmainen H. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem 1994;42(7):945-51.
10. [10] Bremer GL, Tiebosch AT, van der Putten HW, de Haan J, Arends JW. Basement membranes in cervical cancers: relationship to pelvic lymph node metastasis and prognosis. Gynecol Oncol 1995;57(3):351-5.
11. [11] Stewart CJ, McNicol AM. Distribution of type IV collagen immuno-reactivity to assess questionable early stromal invasion. J Clin Pathol 1992;45(1):9-15.
12. [12] Richards CJ, Furness PN. Basement membrane continuity in benign, premalignant and malignant epithelial conditions of the uterine cervix. Histopathology 1990;16(1):47-52.
13. [13] Ehrmann RL, Dwyar IM, Yavner D, Hancock WW. An immunoperoxidase study of laminin and type IV collagen distribution in carcinoma of the cervix and vulva. Obstet Gynecol 1988;72(2):257-62.
14. [14] Sorvari T, Sarnesto A, Syrjanen K. Type IV collagen in the basal membrane of human papillomavirus associated premalignant and malignant squamous cell lesions of the uterine cervix. Gynecol Obstet Invest 1988;26(4):324-31.
15. [15] Vogel HP, Mendelsohn G. Laminin immunostaining in hyperplastic, dysplastic and neoplastic lesions of the endometrium and uterine cervix. Obstet Gynecol 1987;69(5):794-9.
16. [16] Crum CP. Genital papillomavirus and related neoplasms: Causation, diagnosis and classification (Bethesda). Mod Pathol 1994;7(1):138-45.
17. [17] Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979;27(8):1131-9.
18. [18] Giorno R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984;2:161-6.
19. [19] Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, Foidart JM. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1995;65:209-13.
20. [20] Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biagini G. The 72-kDa metalloproteinase immunostaining in cervical carcinoma: Relationship with lymph nodal involvement. Gynecol Oncol 1996;60:271-6.
21. [21] Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL. Correlation of the in situ detection of Polymerase Chain Reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 1995;55:267-75.